Page last updated: 2024-11-05

vitamin k5

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Vitamin K5, also known as menadione, is a synthetic form of vitamin K that is not found naturally in foods. It is a fat-soluble vitamin that plays a critical role in blood clotting and bone health. It is produced through a synthetic process that involves the oxidation of 2-methyl-1,4-naphthoquinone. Vitamin K5 is readily absorbed in the intestines and is converted into its active form, menaquinone, in the liver. Research has shown that vitamin K5 can be effective in treating vitamin K deficiency, which can lead to bleeding disorders. However, high doses of vitamin K5 can be toxic and can cause liver damage. This has led to a reduction in the use of vitamin K5, with menadione sodium bisulfite (MSB) becoming a safer alternative. MSB is water-soluble and rapidly eliminated from the body, leading to a reduced risk of toxicity. Vitamin K5 continues to be studied for its potential in various medical applications, such as the treatment of osteoporosis and cancer. Studies are also ongoing to understand the potential benefits and risks of vitamin K5 in different populations.'

vitamin k5: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6754
CHEMBL ID5191355
CHEBI ID195927
SCHEMBL ID318448
MeSH IDM0082856

Synonyms (40)

Synonym
83-70-5
4-amino-2-methyl-1-naphthol hci
89298-62-4
1-naphthol, 4-amino-2-methyl-
2-methyl-4-amino-1-naphthol
vitamin k5
4-amino-2-methyl-1-naphthol
1-naphthalenol, 4-amino-2-methyl-
1-hydroxy-2-methyl-4-aminonaphthalene
4-amino-2-methyl-1-naphthalenol, hydrochloride
2-methyl-4-amino-1-hydroxynaphthalene
brn 2719282
4-amino-2-methyl-1-naphthalenol
3-methyl-4-hydroxy-1-naphthylamine
synkamin
synkamin base
CHEBI:195927
4-amino-2-methylnaphthalen-1-ol
AKOS006273533
4-hydroxy-3-methyl-1-naphthylammonium chloride
3-13-00-01920 (beilstein handbook reference)
kkp97t7o0x ,
unii-kkp97t7o0x
vitamin k5 base
vitamin k5 [mi]
SCHEMBL318448
4-amino-2-methyl-1-hydroxynaphthalene
UGQFCTZXVAPVCS-UHFFFAOYSA-N
DTXSID3075042
CHEMBL5191355 ,
4-amino-2-methyl-1-naphthalenol, 9ci
1-naphthol, 4-amino-2-methyl-, hydrochloride (8ci)
vitamin k5;1-hydroxy-2-methyl-4-aminonaphthalene;2-methyl-4-amino-1-hydroxynaphthalene;2-methyl-4-amino-1-naphthol;3-methyl-4-hydroxy-1-naphthylamine;4-amino-2-methyl-1-naphthol
BCP09306
synkamin; synkamin base
Q27282311
bdbm50597708
CS-0013859
HY-B1814
EN300-332177

Research Excerpts

Actions

ExcerptReferenceRelevance
"Vitamin K5 was shown to suppress the proliferation of PLC/PRF/5 cells at a concentration of 30 microM."( In vitro and in vivo antitumor effects of vitamin K5 on hepatocellular carcinoma.
Deguchi, A; Hitomi, M; Inoue, H; Kimura, Y; Kuriyama, S; Kurokohchi, K; Masaki, T; Nakai, S; Nonomura, T; Ogawa, M; Uchida, N; Yokoyama, F; Yoshiji, H, 2005
)
1.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
naphtholsAny hydroxynaphthalene derivative that has a single hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Pyruvate kinase PKMHomo sapiens (human)IC50 (µMol)28.00000.50002.788610.0000AID1881870
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
programmed cell deathPyruvate kinase PKMHomo sapiens (human)
canonical glycolysisPyruvate kinase PKMHomo sapiens (human)
positive regulation of sprouting angiogenesisPyruvate kinase PKMHomo sapiens (human)
positive regulation of cytoplasmic translationPyruvate kinase PKMHomo sapiens (human)
glycolytic processPyruvate kinase PKMHomo sapiens (human)
cellular response to insulin stimulusPyruvate kinase PKMHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
magnesium ion bindingPyruvate kinase PKMHomo sapiens (human)
RNA bindingPyruvate kinase PKMHomo sapiens (human)
mRNA bindingPyruvate kinase PKMHomo sapiens (human)
protein tyrosine kinase activityPyruvate kinase PKMHomo sapiens (human)
pyruvate kinase activityPyruvate kinase PKMHomo sapiens (human)
protein bindingPyruvate kinase PKMHomo sapiens (human)
ATP bindingPyruvate kinase PKMHomo sapiens (human)
MHC class II protein complex bindingPyruvate kinase PKMHomo sapiens (human)
potassium ion bindingPyruvate kinase PKMHomo sapiens (human)
cadherin bindingPyruvate kinase PKMHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
extracellular regionPyruvate kinase PKMHomo sapiens (human)
nucleusPyruvate kinase PKMHomo sapiens (human)
cytoplasmPyruvate kinase PKMHomo sapiens (human)
mitochondrionPyruvate kinase PKMHomo sapiens (human)
rough endoplasmic reticulumPyruvate kinase PKMHomo sapiens (human)
cytosolPyruvate kinase PKMHomo sapiens (human)
ciliumPyruvate kinase PKMHomo sapiens (human)
vesiclePyruvate kinase PKMHomo sapiens (human)
secretory granule lumenPyruvate kinase PKMHomo sapiens (human)
collagen-containing extracellular matrixPyruvate kinase PKMHomo sapiens (human)
extracellular exosomePyruvate kinase PKMHomo sapiens (human)
extracellular vesiclePyruvate kinase PKMHomo sapiens (human)
ficolin-1-rich granule lumenPyruvate kinase PKMHomo sapiens (human)
cytoplasmPyruvate kinase PKMHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1881870Inhibition of human N-terminal 6x-His tagged PKM2 expressed Escherichia coli incubated for 60 mins in absence of FBP by LDH-coupled assay2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (65.38)18.7374
1990's0 (0.00)18.2507
2000's3 (11.54)29.6817
2010's5 (19.23)24.3611
2020's1 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.16 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index55.42 (26.88)
Search Engine Supply Index3.89 (0.95)

This Compound (27.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.23%)4.05%
Observational0 (0.00%)0.25%
Other30 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]